Parallax Volatility Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-232
Closed -$20K 1717
2021
Q1
$20K Sell
232
-18,172
-99% -$1.69M ﹤0.01% 1215
2020
Q4
$1.76M Sell
18,404
-15,348
-45% -$1.58M ﹤0.01% 1284
2020
Q3
$3.83M Buy
33,752
+22,249
+193% +$2.34M ﹤0.01% 1441
2020
Q2
$1.14M Buy
11,503
+1,087
+10% +$86.7K ﹤0.01% 1685
2020
Q1
$670K Buy
10,416
+6,994
+204% +$490K ﹤0.01% 1612
2019
Q4
$204K Sell
3,422
-35,036
-91% -$2.16M ﹤0.01% 2004
2019
Q3
$2.27M Buy
+38,458
New +$2.45M ﹤0.01% 1094
2019
Q2
Sell
-1,900
Closed -$123K 3722
2019
Q1
$121K Buy
1,900
+1,650
+660% +$86.7K ﹤0.01% 2075
2018
Q4
$9K Sell
250
-120
-32% -$4.24K ﹤0.01% 2522
2018
Q3
$16K Buy
+370
New +$12.9K ﹤0.01% 2182

Other funds holding TNDM

Parallax Volatility Advisers's TNDM Position: Q2 2021 in Review

Parallax Volatility Advisers sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 232 shares — an estimated $20K sold.

Parallax Volatility Advisers first reported a position in TNDM in Q3 2018 and held it in 10 quarters. The position peaked at $3.83M in Q3 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Parallax Volatility Advisers reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 232 Tandem Diabetes Care shares in Q2 2021, an estimated $20K.
  • Parallax Volatility Advisers first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 10 quarters.
  • Parallax Volatility Advisers's Tandem Diabetes Care position peaked at $3.83M in Q3 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.